AAAAAA
Results:
1-25
|
Results: 25
Authors:
Barker, JNWN
Citation: Jnwn. Barker, Leukocyte trafficking in skin diseases - Introduction, CELL ADHES, 8, 2001, pp. 167-172
Authors:
Ameen, M
Taylor, DA
Williams, IP
Wells, AU
Barker, JNWN
Citation: M. Ameen et al., Pneumonitis complicating methotrexate therapy for pustular psoriasis, J EUR A D V, 15(3), 2001, pp. 247-249
Authors:
Davison, SC
Ballsdon, A
Allen, MH
Barker, JNWN
Citation: Sc. Davison et al., Early migration of cutaneous lymphocyte-associated antigen (CLA) positive T cells into evolving psoriatic plaques, EXP DERMATO, 10(4), 2001, pp. 280-285
Authors:
Ameen, M
Smith, HR
Barker, JNWN
Citation: M. Ameen et al., Combined mycophenolate mofetil and cyclosporin therapy for severe recalcitrant psoriasis, CLIN EXP D, 26(6), 2001, pp. 480-483
Authors:
Millard, TP
Antoniades, L
Evans, AV
Smith, HR
Spector, TD
Barker, JNWN
Citation: Tp. Millard et al., Bone mineral density of patients with chronic plaque psoriasis, CLIN EXP D, 26(5), 2001, pp. 446-448
Authors:
Barker, JNWN
Citation: Jnwn. Barker, Genetic aspects of psoriasis, CLIN EXP D, 26(4), 2001, pp. 321-325
Authors:
Veal, CD
Clough, RL
Barber, RC
Mason, S
Tillman, D
Ferry, B
Jones, AB
Ameen, M
Balendran, N
Powis, SH
Burden, AD
Barker, JNWN
Trembath, RC
Citation: Cd. Veal et al., Identification of a novel psoriasis susceptibility locus at 1p and evidence of epistasis between PSORS1 and candidate loci, J MED GENET, 38(1), 2001, pp. 7-13
Authors:
Davison, SC
Allen, MH
Mallon, E
Barker, JNWN
Citation: Sc. Davison et al., Contrasting patterns of streptococcal superantigen-induced T-cell proliferation in guttate vs. chronic plaque psoriasis, BR J DERM, 145(2), 2001, pp. 245-251
Authors:
Hern, S
Allen, MH
Sousa, AR
Harland, CC
Barker, JNWN
Levick, JR
Mortimer, PS
Citation: S. Hern et al., Immunohistochemical evaluation of psoriatic plaques following selective photothermolysis of the superficial capillaries, BR J DERM, 145(1), 2001, pp. 45-53
Authors:
Ellis, CN
Barker, JNWN
Citation: Cn. Ellis et Jnwn. Barker, Psoriasis: A view for the year 2000, CURR P D-US, 12(2), 2000, pp. 45-50
Authors:
Skov, L
Villadsen, L
Ersboll, BK
Simon, JC
Barker, JNWN
Baadsgaard, O
Citation: L. Skov et al., Long-wave UVA offers partial protection against UVB-induced immune suppression in human skin, APMIS, 108(12), 2000, pp. 825-830
Authors:
Smith, CH
Jackson, K
Chinn, S
Angus, K
Barker, JNWN
Citation: Ch. Smith et al., A double blind, randomized, controlled clinical trial to assess the efficacy of a new coal tar preparation (Exorex) in the treatment of chronic, plaque type psoriasis, CLIN EXP D, 25(8), 2000, pp. 580-583
Authors:
Whittam, LR
Wakelin, SH
Barker, JNWN
Citation: Lr. Whittam et al., Generalized pustular psoriasis or drug-induced toxic pustuloderma? The useof patch testing, CLIN EXP D, 25(2), 2000, pp. 122-124
Authors:
Basarab, T
Millard, TP
McGregor, JM
Barker, JNWN
Citation: T. Basarab et al., Atypical pigmented lesions following extensive PUVA therapy, CLIN EXP D, 25(2), 2000, pp. 135-137
Authors:
Allen, MH
Wakelin, SH
Holloway, D
Lisby, S
Baadsgaard, O
Barker, JNWN
McFadden, JP
Citation: Mh. Allen et al., Association of TNFA gene polymorphism at position-308 with susceptibility to irritant contact dermatitis, IMMUNOGENET, 51(3), 2000, pp. 201-205
Authors:
Whittam, LR
MacDonald, DM
Calonje, E
Breuer, J
Spink, P
Barker, JNWN
Citation: Lr. Whittam et al., Truncal hypopigmented macules and facial hyperpigmented papules, ARCH DERMAT, 136(2), 2000, pp. 260
Authors:
Gollnick, HPM
Finzi, AF
Marks, R
Barker, JNWN
Jansen, C
Revuz, J
Saurat, JH
Citation: Hpm. Gollnick et al., Optimising the use of tazarotene in clinical practice: Consensus statementfrom the European Advisory Panel for Tazaroten (Zorac (TM)), DERMATOLOGY, 199(1), 1999, pp. 40-46
Authors:
Millard, TP
Smith, HR
Black, MM
Barker, JNWN
Citation: Tp. Millard et al., Bullous pemphigoid developing during systemic therapy with chloroquine, CLIN EXP D, 24(4), 1999, pp. 263-265
Authors:
Allen, MH
Veal, C
Faassen, A
Powis, SH
Vaughan, RW
Trembath, RC
Barker, JNWN
Citation: Mh. Allen et al., A non-HLA gene within the MHC in psoriasis, LANCET, 353(9164), 1999, pp. 1589-1590
Authors:
Balendran, N
Clough, RL
Arguello, JR
Barber, R
Veal, C
Jones, AB
Rosbotham, JL
Little, AM
Madrigal, A
Barker, JNWN
Powris, SH
Trembath, RC
Citation: N. Balendran et al., Characterization of the major susceptibility region for psoriasis at chromosome 6p21.3, J INVES DER, 113(3), 1999, pp. 322-328
Authors:
Dittmar, HC
Weiss, JM
Termeer, CC
Denfeld, RW
Wanner, MB
Skov, L
Barker, JNWN
Schopf, E
Baadsgaard, O
Simon, JC
Citation: Hc. Dittmar et al., In vivo UVA-1 and UVB irradiation differentially perturbs the antigen-presenting function of human epidermal Langerhans cells, J INVES DER, 112(3), 1999, pp. 322-325
Authors:
Barker, JNWN
Ashton, RE
Marks, R
Harris, RI
Berth-Jones, J
Citation: Jnwn. Barker et al., Topical maxacalcitol for the treatment of psoriasis vulgaris: a placebo-controlled, double-blind, dose-finding study with active comparator, BR J DERM, 141(2), 1999, pp. 274-278
Authors:
Clark, CM
Kirby, B
Morris, AD
Davison, S
Zaki, I
Emerson, R
Saihan, EM
Chalmers, RJG
Barker, JNWN
Allen, BR
Griffiths, CEM
Citation: Cm. Clark et al., Combination treatment with methotrexate and cyclosporin for severe recalcitrant psoriasis, BR J DERM, 141(2), 1999, pp. 279-282
Authors:
Davison, S
Allen, M
Harmer, A
Vaughan, R
Barker, JNWN
Citation: S. Davison et al., Increased T-cell receptor V beta 2 chain expression in skin homing lymphocytes in psoriasis, BR J DERM, 140(5), 1999, pp. 845-848
Authors:
Barker, JNWN
Citation: Jnwn. Barker, Psoriasis as a T cell-mediated autoimmune disease, HOSP MED, 59(7), 1998, pp. 530-533
Risultati:
1-25
|